Oxford Financial Group’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$284K Sell
1,344
-10
-0.7% -$2.15K 0.02% 220
2025
Q4
$278K Buy
1,354
+15
+1% +$2.82K 0.02% 197
2025
Q3
$210K Hold
1,339
0.01% 217
2025
Q2
$225K Buy
+1,339
New +$199K 0.01% 193
2024
Q2
Sell
-3,436
Closed -$384K 321
2024
Q1
$384K Buy
3,436
+31
+0.9% +$3.35K 0.03% 158
2023
Q4
$343K Hold
3,405
0.03% 168
2023
Q3
$296K Sell
3,405
-35
-1% -$3.16K 0.03% 171
2023
Q2
$325K Sell
3,440
-52
-1% -$4.39K 0.03% 173
2023
Q1
$264K Hold
3,492
0.03% 163
2022
Q4
$268K Buy
3,492
+87
+3% +$6.61K 0.03% 168
2022
Q3
$227K Buy
+3,405
New +$216K 0.03% 161
2021
Q3
Sell
-3,583
Closed -$205K 245
2021
Q2
$205K Hold
3,583
0.03% 174
2021
Q1
$218K Buy
+3,583
New +$198K 0.03% 166

Other funds holding CAH

Oxford Financial Group's CAH Position: Q1 2026 in Review

Oxford Financial Group reduced its Cardinal Health (CAH) stake by 0.74% in Q1 2026, selling an estimated $2.15K and leaving 1,344 shares worth $284K. The position accounts for 0.02% of the portfolio, ranked #220.

Oxford Financial Group first reported a position in CAH in Q1 2021 and has held it in 13 quarters since. The position peaked at $384K in Q1 2024. 1,425 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Oxford Financial Group held 1,344 shares of Cardinal Health worth $284K as of Q1 2026.
  • Oxford Financial Group sold 10 Cardinal Health shares in Q1 2026, an estimated $2.15K.
  • Cardinal Health made up 0.02% of Oxford Financial Group's portfolio in Q1 2026, its #220 holding.
  • Oxford Financial Group first reported a position in Cardinal Health in Q1 2021 and has held it in 13 quarters since.
  • Oxford Financial Group's Cardinal Health position peaked at $384K in Q1 2024.
  • 1,425 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Oxford Financial Group's 13F filing for Q1 2026, filed 6 May 2026.